New Alzheimer's drugs bring hope, controversy

The two new drugs are said to help slow the progression of Alzheimer's, but the Center for Medicare and Medicaid Services won't cover the $26,000 a year prescription price tag because it's not sure just how safe the drugs are.

Related Keywords

Texas ,United States ,Dallas ,Randy Haberer ,Dozier Carter ,Jan Vanvliet ,Sid Obryant ,Sidney Halbardier ,Centers For Medicare ,Alzheimer Association ,Medicaid Services ,Health Science Center ,Dallas City Hall ,Sido Bryant ,North Texas ,Groundbreaking Alzheimer ,Health ,News ,Us ,Tx ,Dallas County ,